PULM PT 2 3/13

Introduction to Lung Cancer and Related Conditions

  • Overview of presentation symptoms:
    • Common symptoms include cough, hemoptysis, and shortness of breath.
    • Many patients may be unaware of underlying cancer until discovered on imaging like chest x-ray or CT scan.

Key Imaging and Monitoring Guidelines

  • Indicators for concern when evaluating masses on imaging:
    • Lesion size over three centimeters with a comparison to previous scans suggests growth.
    • Follow-up imaging may be warranted if lesions show growth exceeding two millimeters per month.
    • Presence of pleural nodularity may indicate mesothelioma, particularly in patients with asbestos exposure.
    • A history of at least twenty years of asbestos exposure is significant for mesothelioma.
    • Hilar lymphadenopathy and endobronchial lesions are suspicious for lung cancer.
  • Persistent pneumonia consolidation unresponsive to antibiotics may indicate an underlying malignancy.

Screening for Lung Cancer

  • The significance of screening in reducing lung cancer burden.
  • Importance of screening in non-smokers, emphasizing that non-smokers are also at risk for lung cancer.
  • Historical prevalence: adenocarcinoma was primarily seen in non-smokers but is now common in smokers and particularly in women.
  • Smoking cessation reduces lung cancer risk significantly, accounting for 85%-90% of lung cancer cases.

Cancer Types and Survival Rates

  • Lung cancer remains the leading cause of death among adults; survival rates significantly lower if metastasized.
  • Serial imaging and lung biopsy are crucial for diagnosis and management of different lung cancers.

Benign vs Malignant Findings

  • Positive screening results could lead to identification of benign nodes, requiring invasive studies like bronchoscopy and bronchoalveolar lavage.
  • Invasive procedures have risks, including potential cancer spread; careful evaluation of patient history is crucial.
  • Low-dose CT scans recommended for monitoring due to radiation exposure concerns.

Age and Cancer Risk

  • Increased cancer risk in individuals aged 50-80 years due to decreased DNA repair mechanisms with age.

Understanding the "Pack-Year" Concept

  • Definition: A 20 pack-year smoker refers to smoking one pack per day for twenty years.
  • Implications for lung cancer risk and screening recommendations based on smoking history.

Lung Cancer Classifications

  • Lung cancers categorized as bronchogenic carcinomas:
    1. Small cell carcinomas
    2. Non-small cell lung cancers
  • Primary risk factors remain cigarette smoking and second-hand smoke exposure.
    • Radon gas exposure is another significant risk factor, often overlooked in household safety measures.

Chronic Obstructive Pulmonary Disease (COPD)

  • COPD includes diseases such as emphysema and chronic bronchitis, primarily caused by smoking.
    • Types of emphysema: central lobular emphysema linked with smoking, and pan lobular emphysema linked with genetic factors (alpha-1 antitrypsin deficiency).

Non-Small Cell Lung Cancer (NSCLC) Types

  • NSCLC subtypes:
    1. Adenocarcinoma
    2. Squamous cell carcinoma
    3. Large cell carcinoma
  • Adenocarcinoma: usually peripheral, more common in women and increasingly in smokers.
  • Squamous cell carcinoma: typically occurs in upper tracheobronchial tree, associated with changes in phonation and cavitary lesions.
  • Large cell carcinoma: aggressive, poor prognosis, difficult to classify.

Small Cell Lung Cancer (SCLC)

  • SCLC characterized by:
    • Very aggressive behavior with low survival rates (5-10%).
    • Represents about 15% of lung cancers, majorly linked to smoking.
    • Common metastasis sites include adrenal glands, liver, and lymph nodes.
    • Treatment typically involves chemotherapy and radiation therapy due to rapid spread.

Paraneoplastic Syndromes

  • SCLC can cause paraneoplastic syndromes leading to unusual symptoms (e.g., hormone production).
  • Lambert-Eaton Myasthenic Syndrome associated with small cell lung cancer presents with weakness and autonomic symptoms.

Superior Vena Cava Syndrome

  • Classic presentation involves dyspnea, neck and chest wall venous distension due to tumor compression of the superior vena cava.

Neuroendocrine Tumors

  • Categories include carcinoid tumors, which can present with symptoms like diarrhea and rash.
  • Well-differentiated carcinoid tumors have favorable prognosis; atypical carcinoid tumors exhibit a more aggressive behavior.
    • MEN1 syndrome associations and prognostic measures for these tumors.

Summary and Conclusions

  • Understanding the etiology, risks, classifications, clinical presentations, and management options for lung cancer and associated conditions is vital for improving patient outcomes.